PAncreas Borderline and Locally Advanced Snapshot Study

* Multicenter, observational prospective study over one year in France in patients with borderline or locally advanced pancreatic adenocarcinoma operated between September 2022 and August 2023. * Patients will be screened by the pancreatic's surgeons practicing in a reference centers during preoperative surgical consultations (V1), * The patient's non-objection will be sollected, * The end of follow-up's patient will take place during the post-operative consultation approximately 3 months after surgery (V3) * Between V1 and V3, preoperative data (demography, history, tumor characteristics, neoadjuvant treatments performed, tumor response), operative, intraoperative, pathological and postoperative data will be collected via a e-CRF " the REDCAP software".